We evaluated the presence of cancer-associated fibroblasts (CAFs) and subtypes associated with PDAC using subsets defined by podoplanin, aSMA and platelet-derived growth factor receptor (PDGFR), and found no significant changes in DRP-104-treated tumors (Extended Data Fig. 8a–d). The gene discussed is PDPN; the disease is cancer.